Tom Nguyen

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Squamous Cell Carcinoma

Top Venues

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors. Cancer discovery (2024)
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors. Cancer discovery 14 (8) (2024)
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors. Cancer discovery 14 (8) (2024)
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors. Cancer discovery 14 (8) (2024)